Literature DB >> 24851164

Sevoflurane versus propofol for interventional neuroradiology: a comparison of the maintenance and recovery profiles at comparable depths of anesthesia.

Eun-Su Choi1, Ji Yeon Shin2, Ah Young Oh1, Hee-Pyoung Park2, Jung-Won Hwang1, Young Jin Lim2, Young-Tae Jeon1.   

Abstract

BACKGROUND: Sevoflurane and propofol are used widely for interventional neuroradiology (INR). Using the bispectral index (BIS), we compared the clinical properties of sevoflurane and propofol anesthesia in patients undergoing INR at comparable depths of anesthesia.
METHODS: The patients were allocated randomly into two groups. The sevoflurane group received propofol (1.5 mg/kg), alfentanil (5 µg/kg), and rocuronium (0.6 mg/kg) for induction, and the propofol group was induced with a target effect-site concentration of propofol (4 µg/ml), alfentanil (5 µg/kg), and rocuronium (0.6 mg/kg). After intubation, anesthesia was maintained with sevoflurane or propofol with 67% nitrous oxide in 33% oxygen. Sevoflurane and propofol concentrations were titrated to maintain the BIS at 50-60. Phenylephrine or opioid was used to maintain the mean arterial pressure within 20% of the baseline values. The amounts of phenylephrine or alfentanil used, the number of patients showing movement during the procedure, and the recovery times were recorded.
RESULTS: Compared to the propofol group, the sevoflurane group showed faster recovery in spontaneous ventilation, eye opening, extubation, and orientation (4 vs. 7 min, 7 vs. 9 min, 8 vs. 10 min, 10 vs. 14 min, respectively; P < 0.01). In the propofol group, significantly greater amounts phenylephrine were used (P < 0.05), and more patients moved during the procedure (P < 0.05).
CONCLUSIONS: The use of sevoflurane in maintaining anesthesia during INR was associated with faster recovery, less patient movement during the procedure, and a more stable hemodynamic response when compared to propofol.

Entities:  

Keywords:  Bispectral index; Interventional radiology; Propofol; Sevoflurane

Year:  2014        PMID: 24851164      PMCID: PMC4028556          DOI: 10.4097/kjae.2014.66.4.290

Source DB:  PubMed          Journal:  Korean J Anesthesiol        ISSN: 2005-6419


  18 in total

1.  Hypnotic endpoints vs. the bispectral index, 95% spectral edge frequency and median frequency during propofol infusion with or without fentanyl.

Authors:  W D Mi; T Sakai; H Singh; T Kudo; M Kudo; A Matsuki
Journal:  Eur J Anaesthesiol       Date:  1999-01       Impact factor: 4.330

Review 2.  Anaesthetic considerations for interventional neuroradiology.

Authors:  M K Varma; K Price; V Jayakrishnan; B Manickam; G Kessell
Journal:  Br J Anaesth       Date:  2007-06-11       Impact factor: 9.166

Review 3.  Does opioid "anesthesia" exist?

Authors:  C C Hug
Journal:  Anesthesiology       Date:  1990-07       Impact factor: 7.892

4.  Haemodynamic and electroencephalograph responses to intubation during induction with propofol or propofol/fentanyl.

Authors:  W D Mi; T Sakai; S Takahashi; A Matsuki
Journal:  Can J Anaesth       Date:  1998-01       Impact factor: 5.063

5.  Prediction of movement during propofol/nitrous oxide anesthesia. Performance of concentration, electroencephalographic, pupillary, and hemodynamic indicators.

Authors:  K Leslie; D I Sessler; W D Smith; M D Larson; M Ozaki; D Blanchard; D P Crankshaw
Journal:  Anesthesiology       Date:  1996-01       Impact factor: 7.892

6.  General anesthesia for interventional neuroradiology: propofol versus isoflurane.

Authors:  S Münte; T F Münte; H Kuche; A Osthaus; T Herzog; J Heine; M Leuwer; S Piepenbrock
Journal:  J Clin Anesth       Date:  2001-05       Impact factor: 9.452

7.  Recovery from sevoflurane anesthesia: a comparison to isoflurane and propofol anesthesia.

Authors:  T J Ebert; B J Robinson; T D Uhrich; A Mackenthun; P J Pichotta
Journal:  Anesthesiology       Date:  1998-12       Impact factor: 7.892

8.  Propofol and autonomic reflex function in humans.

Authors:  T J Ebert; M Muzi
Journal:  Anesth Analg       Date:  1994-02       Impact factor: 5.108

9.  Sevoflurane for interventional neuroradiology procedures is associated with more rapid early recovery than propofol.

Authors:  Hugo E Castagnini; Frank van Eijs; Frederick C Salevsky; Michael H Nathanson
Journal:  Can J Anaesth       Date:  2004-05       Impact factor: 5.063

10.  Neurogenic pulmonary edema following intracranial coil embolization for subarachnoid hemorrhage -A case report-.

Authors:  Jeong Eun Kim; Ji Hye Park; Sung Hyun Lee; Yoonki Lee
Journal:  Korean J Anesthesiol       Date:  2012-10-12
View more
  6 in total

1.  The Effect of Sevoflurane Plus Propofol on Pain and Complications after Laminectomy: A Randomized Double Blind Clinical Trial.

Authors:  Aminolah Vasigh; Fatemeh Najafi; Molouk Jaafarpour; Javaher Khajavikhan; Ali Khani
Journal:  J Clin Diagn Res       Date:  2017-04-01

2.  The optimal anesthetic depth for interventional neuroradiology: comparisons between light anesthesia and deep anesthesia.

Authors:  Yoo Sun Jung; Ye-Reum Han; Eun-Su Choi; Byung-Gun Kim; Hee-Pyoung Park; Jung-Won Hwang; Young-Tae Jeon
Journal:  Korean J Anesthesiol       Date:  2015-03-30

Review 3.  A clinical review of inhalation anesthesia with sevoflurane: from early research to emerging topics.

Authors:  Jorge D Brioni; Shane Varughese; Raza Ahmed; Berthold Bein
Journal:  J Anesth       Date:  2017-06-05       Impact factor: 2.078

4.  Safety of Inhalational Anesthesia in Patients with Multiple Drug Allergies Presenting for Major Surgeries under General Anesthesia.

Authors:  Sunil Rajan; Jacob Mathew; Pulak Tosh; Manu Sudevan
Journal:  Anesth Essays Res       Date:  2019 Apr-Jun

5.  Comparison of Two Methods of Anesthesia Using Patient State Index: Propofol Versus Sevoflurane During Interventional Neuroradiology Procedure.

Authors:  Eunsu Kang; Ki Hwa Lee; Jae-Hong Park
Journal:  Anesth Pain Med       Date:  2019-04-16

6.  AMPK‑SIRT1 pathway dysfunction contributes to neuron apoptosis and cognitive impairment induced by sevoflurane.

Authors:  Liwei Liu; Chao Liu; Lin Fang
Journal:  Mol Med Rep       Date:  2020-11-17       Impact factor: 2.952

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.